Effects of 3′,4′-dihydroxyflavonol on vascular contractions of rat aortic rings

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 8, 2010, Pages 803-810

  Song, Min Ji ^a   Baek, Inji ^a   Seo, Minchul ^a   Kim, Sang Hyun ^a   Suk, Kyoungho ^a   Woodman, Owen L ^b   Williams, Spencer J ^c   Kim, In Kyeom ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

3 ,4 dihydroxyflavonol; CPI 17; myosin phosphatase target subunit 1 (MYPT1); Rho kinase; RhoA; vasorelaxation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3',4' DIHYDROXYFLAVONOL; 4 AMINOPYRIDINE; APAMIN; CHARYBDOTOXIN; DODECYL SULFATE SODIUM; GLIBENCLAMIDE; MYOSIN LIGHT CHAIN; PROTEIN KINASE C; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VASODILATOR AGENT; 3',4'-DIHYDROXYFLAVONOL; FLAVONOL DERIVATIVE; FLUORIDE SODIUM; MUSCLE PROTEIN; PHENYLEPHRINE; PHOSPHOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; PPP1R12A PROTEIN, RAT; PPP1R14A PROTEIN, RAT; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; AORTA; ARTICLE; DRUG EFFECT; ENDOTHELIUM; ENZYME ACTIVATION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PHOSPHORYLATION; RAT; VASCULAR RING; VASODILATATION; WESTERN BLOTTING; ANIMAL; BIOTRANSFORMATION; DOSE RESPONSE; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; AORTA, THORACIC; BIOTRANSFORMATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLAVONOLS; MALE; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; PHENYLEPHRINE; PHOSPHOPROTEINS; PHOSPHORYLATION; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHLORIDE; PROTEIN PHOSPHATASE 1; RATS; RATS, SPRAGUE-DAWLEY; RHOA GTP-BINDING PROTEIN; SODIUM FLUORIDE; VASOCONSTRICTOR AGENTS;

EID: 77955097715     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05384.x     Document Type: Article

References (34)

1. Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler. Thromb. Vasc. Biol. 2005 25:1767 1775.
2. Budzyn K, Marley PD, Sobey CG. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends Pharmacol. Sci. 2006 27:97 104.
3. Lai A, Frishman WH. Rho-kinase inhibition in the therapy of cardiovascular disease. Cardiol. Rev. 2005 13:285 292.
4. Uehata M, Ishizaki T, Satoh H et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997 389:990 994.
5. Wirth A, Benyo Z, Lukasova M et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat. Med. 2008 14:64 8.
6. Wang S, Dusting GJ, May CN, Woodman OL. 3′,4′- Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep. Br. J. Pharmacol. 2004 142:443 452.
7. Wang S, Fei K, Xu YW, Wang LX, Chen YQ. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats. Chin. Med. J. 2009 122:61 7.
8. Chan EC, Drummond GR, Woodman OL. 3′,4′-Dihydroxyflavonol enhances nitric oxide bioavailability and improves vascular function after ischemia and reperfusion injury in the rat. J. Cardiovasc. Pharmacol. 2003 42:727 735.
9. Woodman OL, Chan E. Vascular and anti-oxidant actions of flavonols and flavones. Clin. Exp. Pharmacol. Physiol. 2004 31:786 790.
10. Chan EC, Pannangpetch P, Woodman OL. Relaxation to flavones and flavonols in rat isolated thoracic aorta. Mechanism of action and structure-activity relationships. J. Cardiovasc. Pharmacol. 2000 35:326 333.
11. Qin CX, Chen X, Hughes RA, Williams SJ, Woodman OL. Understanding the cardioprotective effects of flavonols: Discovery of relaxant flavonols without antioxidant activity. J. Med. Chem. 2008 51:1874 1884.
12. Wang S, Dusting GJ, Woodman OL, May CN. Selective vasodilator and chronotropic actions of 3′,4′-dihydroxyflavonol in conscious sheep. Eur. J. Pharmacol. 2004 491:43 51.
13. National Institutes of Health. Guide for the Care and Use of Laboratory Animals. NIH publication No. 85-23, revised edn. National Institutes of Health
14. Seok YM, Baek I, Kim YH et al. Isoflavone attenuates vascular contraction through inhibition of the RhoA/Rho-kinase signaling pathway. J. Pharmacol. Exp. Ther. 2008 326:991 998.
15. Kawano Y, Yoshimura T, Kaibuchi K. Smooth muscle contraction by small GTPase Rho. Nagoya J. Med. Sci. 2002 65:1 8.
16. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 2001 22:32 9.
17. Siehler S. Regulation of RhoGEF proteins by G(12/13)-coupled receptors. Br. J. Pharmacol. 2009 158:41 9.
18. 2+ sensitivity of smooth muscle and nonmuscle myosin II. Modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 2003 83:1325 1358.
19. Yang E, Jeon SB, Baek I, Chen ZA, Jin Z, Kim IK. 17Beta-estradiol attenuates vascular contraction through inhibition of RhoA/Rho kinase pathway. Naunyn Schmiedebergs Arch. Pharmacol. 2009 380:35 44.
20. Baek I, Jeon SB, Song MJ, Yang E, Sohn UD, Kim IK. Flavone attenuates vascular contractions by inhibiting RhoA/Rho-kinase pathway. Korean J. Physiol. Pharmacol. 2009 13:201 207.
21. 2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem. J. 2005 389:763 774.
22. Mehta D, Rahman A, Malik AB. Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J. Biol. Chem. 2001 276:22614 22620.
23. Eto M, Ohmori T, Suzuki M, Furuya K, Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J. Biochem. 1995 118:1104 1107.
24. Eto M, Kitazawa T, Yazawa M, Mukai H, Ono Y, Brautigan DL. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J. Biol. Chem. 2001 276:29072 29078.
25. Niiro N, Koga Y, Ikebe M. Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle. Biochem. J. 2003 369:117 128.
26. Pang H, Guo Z, Su W, Xie Z, Eto M, Gong MC. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2005 289:C352 60.
27. Ito M, Nakano T, Erdodi F, Hartshorne DJ. Myosin phosphatase: Structure, regulation and function. Mol. Cell. Biochem. 2004 259:197 209.
28. Feng J, Ito M, Ichikawa K et al. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J. Biol. Chem. 1999 274:37385 37390.
29. 2+ sensitization in rabbit smooth muscle. J. Physiol. 2003 546:879 889.
30. Tsai MH, Jiang MJ. Rho-kinase-mediated regulation of receptor-agonist- stimulated smooth muscle contraction. Pflügers Arch. 2006 453:223 232.
31. Jackson WF. Ion channels and vascular tone. Hypertension 2000 35:173 178.
32. 2+ signal transduction in airway smooth muscles. J. Theor. Biol. 2008 252:474 481.
33. Mita M, Yanagihara H, Hishinuma S, Saito M, Walsh MP. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem. J. 2002 364:431 440.
34. 2+ entry of rat penile small arteries. Am. J. Physiol. Heart Circ. Physiol. 2008 294:H1923 32.